Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-04-10
著者
-
佐治 重衡
東京都立駒込病院乳腺外科
-
佐治 重衡
鷲見病院外科
-
Ueno Takayuki
Department Of Bioengineering Graduate School Of Engineering Osaka City University
-
Toi Masakazu
聖路加国際病院 ブレストセンター
-
Iwata Hiroji
Department of Breast Surgery, Aichi Cancer Center
-
Saji S
Department Of Tumor And General Surgery Division Of Cellular And Molecular Biology Gifu University S
-
Ohno Shinji
Department Of Breast Oncology National Kyushu Cancer Center
-
Ohno Shinji
Department Of Breast Surgery National Kyushu Cancer Center
-
Toi Masakazu
Epartment Of Surgery Tokyo Metropolitan Komagome Hospital
-
Toi Masakazu
Department Of Breast Surgery Graduate School Of Faculty Of Medicine Kyoto University
-
Toi Masakazu
Division Of Clinical Trials And Research Breast Cancer Research And Treatment Program Tokyo Metropol
-
Saji Shigehira
Department Of Surgery Tokyo Metropolitan Komagome Hospital
-
Saji Shigehira
Epartment Of Surgery Tokyo Metropolitan Komagome Hospital
-
Saji Shigehira
Division Of Clinical Trials And Research Department Of Breast Surgery And Oncology Tokyo Metropolita
-
AOGI Kenjiro
Department of Clinical Research and Surgery, Shikoku Cancer Center
-
SATO Nobuaki
Department of Astronomy,University of Tokyo
-
Takada Masahiro
Department Of Astronomy
-
Iwata Hiroji
Department Of Breast Oncology Aichi Cancer Center Hospital
-
Toi Masakazu
Department Of Surgery Breast Oncology Unit Tokyo Metropolitan Komagome Hospital
-
Sasano Hironobu
Department Of Anatomic Pathology Tohoku University School Of Medicine
-
Yamamoto Yukiya
Department Of Infectious Disease Nagoya University School Of Medicine
-
Masuda Norikazu
Department Of Surgery National Hospital Organization Osaka National Hospital
-
Yamashiro Hiroyasu
Department Of Surgery Tokyo Metropolitan Cancer And Infectious Disease Center Komagome Hospital
-
Takada Masahiro
Department Of Surgery Tokyo Metropolitan Cancer And Infectious Disease Center Komagome Hospital
-
Suzuki Takashi
Department Of Biochemistry University Of Shizuoka School Of Pharmaceutical Sciences:core Research Fo
-
Hisamatsu Kazufumi
Department Of Surgery Hiroshima City Asa Hospital
-
IWATA Hiroji
Aichi Cancer Center
-
TOI Masakazu
Kyoto University Hospital
-
KUROI Katsumasa
Tokyo Metropolitan Komagome Hospital
-
Saji Shigehira
Second Department Of Surgery Gifu University School Of Medicine
-
Takei Hiroyuki
Division Of Breast Surgery Saitama Cancer Center
-
Iwase Hirotaka
Department Of Breast And Endocrine Surgery Kumamoto University
-
Yamashita Hiroko
Department Of Breast And Endocrine Surgery Nagoya City University
-
Yamashita Hiroko
Department Of Oncology Immunology And Surgery Nagoya City University Graduate School Of Medical Scie
-
TOI Masakazu
National Institute of Infectious Diseases
-
Yamamoto Yutaka
Department Of Breast And Endocrine Surgery Graduate School Of Medical Sciences Kumamoto University
-
Kuroi Katsumasa
Department Of Surgery Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Saji Shigehira
Department Of Breast Surgery Tokyo Metropolitan Komagome Hospital
-
Kuroi Katsumasa
Department Of Breast Surgery Tokyo Metropolitan Komagome Hospital
-
SAJI Shigetoyo
Japanese Foundation for Multidisciplinary Treatment of Cancer(JFMC)
-
CHANPLAKORN Niramol
Department of Pathology, Tohoku University
-
Sato Nobuaki
Department Of Astronomy Faculty Of Science University Of Tokyo
-
Toi Masakazu
Division Of Clinical Trials And Research Breast Cancer Research And Treatment Program Tokyo Metropol
-
Sato Nobuaki
Department Of Surgery Niigata Cancer Center
-
Yamamoto Yutaka
Department Of Applied Analysis And Complex Dynamical Systems Graduate School Of Informatics Kyoto Un
-
Sasano Hironobu
Department Of Pathology Tohoku University
-
Ueno Takayuki
Department Of Surgery (breast Surgery) Kyoto University
-
Aogi Kenjiro
Department Of Breast Oncology National Hospital Organization Shikoku Cancer Center
-
Aogi Kenjiro
Department Of Surgery National Shikoku Cancer Center
-
Chanplakorn Niramol
Department Of Pathology Tohoku University
-
Suzuki Takashi
Department Of Pathology Tohoku University
-
Suzuki Takashi
Department Of Biochemistry School Of Pharmaceutical Sciences And Global Coe Program School Of Pharma
-
Suzuki Takashi
Department Of Anesthesia Showa University Northern Yokohama Hospital
-
Kuroi Katsumasa
Department Of Breast Surgery Tokyo Metropolitan Cancer And Infectious Diseases Center Komagome Hospital
-
Yamashita Hiroko
Department Of Oncology Immunology And Surgery Nagoya City University Graduate School Of Medical Sciences
-
Suzuki Takashi
Department Of Anatomic Pathology Tohoku University School Of Medicine
-
Saji Shigetoyo
Japanese Foundation for Multidisciplinary Treatment of Cancer [JFMC]
関連論文
- ASCO2007,サンアントニオ2006トピックス--内分泌療法 (これからの乳癌診療 2008〜2009) -- (薬物療法)
- Transient late-onset ischemic mitral regurgitation following Dor's procedure
- HER2を標的とした臨床試験の現状と今後の展望 乳がん (特集 分子標的マーカーに基づいた臨床試験)
- 人乳癌細胞MCF-7におけるエストラジオールのp53protein stabilityにおよぼす影響について
- 癌遺伝子産物MDM2と核内受容体Estrogen Receptorのクロストーク
- PP35 乳癌におけるMDM2遺伝子の転写亢進のメカニズム
- ドクターズ・ディベィト 集学的治療カンファレンス(第30回)乳がん 遠隔再発の予防と治療
- 当院における術後放射線治療を行った乳癌乳房温存療法例の治療成績
- 示-337 慢性膵炎合併症の治療 : 特に血管合併症に関して(示-膵臓-6(膵炎))
- HP-073-7 乳癌術前化学療法(NAC)前のセンチネルリンパ節生検(pre-treatment SNB:PSNB)症例についての検討(乳がん(センチネル2),ハイブリッドポスター,第109回日本外科学会定期学術集会)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 予後をどのように予想するか(ER,PgR,HER2などの検討) (特集 乳がん患者への適切な対応) -- (乳がんの診断--見落とさないためのノウハウ)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- エストロゲンレセプター陽性乳癌におけるMDM2の役割
- OK-432・IL-2含有W/O型エマルジョンの転移性肝癌に対する治療効果とその作用機序の検討
- p53によるエストロゲンレセプターの活性阻害とMDM2の関与
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- DP-177-3 乳腺扁平上皮癌自験例10例の臨床病理学的特徴と予後(第107回日本外科学会定期学術集会)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- 乳癌術後患者の健康関連QOL予測因子(Women's Health Outcome Study-01)
- Left Ventricular Reconstruction with or without Mitral Annuloplasty
- Impact of Subvalvular Procedure for Ischemic Mitral Regurgitation on Leaflet Configuration, Mobility, and Recurrence
- 5 Subvalvular Procedure for Ischemic Mitral Regurgitation improved Anterior Leaflet Configuration and Motion with Reduction of Recurrence(Symposium 9 (SY-09) (M) New Insight for Treatment of Ischemic Mitral Regurgitation,Special Program,The 72nd Annual Sc
- Intraoperative infusion of epoprostenol sodium for patients with heparin-induced thrombocytopenia undergoing cardiac surgery
- PJ-285 Diastolic Mitral Valve Area is Smaller Than Annular Area in Patients with Surgical Annuloplasty(Vascular heart disease/Pericarditis/Cardiac tumor-4 (M) PJ48,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Ci
- HER2陽性転移再発乳がんの薬物療法 (焦点 最新! 乳がんの化学療法・ホルモン療法とケア)
- PJ-605 Mechanism of Late-Onset Ischemic Mitral Regurgitation Following Dor's Plasty : Potential Relation to Increased Left Ventricular Filling Pressure Inducing Later Remodeling.(Valvular Heart Disease/Pericarditis/Cardiac Tumor 3 (M) : PJ102)(Poster Sess
- Significance of Membrane Type 1 Matrix Metalloproteinase Expression in Breast Cancer
- ホルモン感受性,非感受性 ホルモン療法の効果予測 (乳癌--基礎と臨床の架け橋)
- LH-RHアゴニストおよび抗エストロゲン療法について : Luteinizing Hormone-Releasing Hormone agonist (LH-RHa) and anti Estrogen Therapy
- 閉経前乳癌の治療 (特集 分子標的のプロトタイプとしてのホルモン療法)
- SF-032-3 乳癌術前化学療法における病理学的評価方法標準化の必要性
- SF-032-2 乳癌細胞株MCF-7に対するRofecoxibの増殖抑制効果
- 乳癌における術後補助内分泌療法 (特集 ホルモン療法の最近の進歩)
- 局所・全身治療法適応決定のための,initial sentinel lymph node biopsyの重要性
- Estrogen Receptor beta cx. As a novel predictive factor of endocrine therapy in ERalpha-positive breast cancer
- A novel Decision-Tree and paradigms for primary breast cancer
- 乳癌治療における「標準」について (21世紀の外科的癌治療指針(1)乳癌治療)
- 8. 乳房切除術の適応(乳癌手術の現況とその根拠)
- ヒト化抗Her2モノクローナル抗体Herceptin治療の有用性と問題点
- 乳癌再発防止にどこまで有用か 進化したホルモン療法 (乳癌のホルモン療法 21世紀の展開)
- 血管新生からみた乳癌の悪性度 : 血管新生は何を反映するのか
- ヒト腫瘍におけるホルモン受容体の発現様式 (あゆみ 乳癌のホルモン療法--最新動向)
- Application of selective estrogen receptor modulators for breast cancer treatment according to their intrinsic nature
- Early breast cancer
- Current Status of Antibody Therapy for Breast Cancer
- Clinical Impact of Assay of Estrogen Receptor βcx in Breast Cancer
- Estradiol Stabilizes p53 Protein in Breast Cancer Cell Line, MCF-7
- 投与にまつわるベーシック講座 (特集 7daysでかならずステップアップ! 消化器がん化学療法まるわかり塾)
- 抗悪性腫瘍薬 エベロリムス(アフィニトール)
- Large Solitary Fibrous Tumor of the Retroperitoneum : Report of a Case
- Evaluation of Carcinoembryonic Antigen mRNA in Living, Necrotic, and Apoptotic Gastric Cancer Cells by Reverse Transcriptase-Polymerase Chain Reaction
- Significance of Apoptosis Induced by Tumor Necrosis Factor-α and/or Interferon-γ Against Human Gastric Cancer Cell Lines and the Role of the p53 Gene
- Prediction of 5-Fluorouracil and Cisplatin Synergism for Advanced Gastrointestinal Cancers Using a Collagen Gel Droplet Embedded Culture
- 胃癌細胞株におけるp53発現と抗癌剤(5FU+CDDP)及びサイトカイン(TNFα+IFNγ)によるアポトーシス誘導の特徴-マイクロアレイでの検討-
- Clinical Significance of Observation of Micrometastasis in Regional Lymph Nodes Using Reverse Transcriptase-Polymerase Chain Reaction for Carcinoembryonic Antigen and Cytokeratin 20 against Cumulative Disease-Free Survival in Colorectal Cancer
- Polo-like kinase 1 (PLK1) is overexpressed in primary colorectal cancers
- Evaluation of Treatment for Synchronous Hepatic Metastases from Gastric Cancer with Special Reference to Long-Term Survivors
- Antitumor Effects Induced by the Combination of TNP-470 as an Angiogenesis Inhibitor and Lentinan as a Biological Response Modifier in a Rabbit Spontaneous Liver Metastasis Model
- Intrahepatic cholangiocarcinoma arising 10 years after the excision of congenital extrahepatic biliary dilation
- A Simple Method for Classification of Cell Death by Use of Thin Layer Collagen Gel for the Detection of Apoptosis and/or Necrosis after Cancer Chemotherapy
- A Ruptured Pancreaticoduodenal Artery Aneurysm Associated with a Splenic Artery Aneurysm : Report of a Case
- Therapeutic Effect of TNP-470 on Spontaneous Liver Metastasis of Colon Tumors in the Rabbit
- Centrosomal Kinases, HsAIRK1 and HsAIRK3, are Overexpressed in Primary Colorectal Cancers
- Rapid Growth of a Retroperitoneal Rhabdomyosarcoma Following Right Hemicolectomy for Ascending Colon Cancer : Report of a Case
- Recurrence of Giant Adrenocortical Carcinoma in the Contralateral Adrenal Gland 6 Years After Surgery : Report of a Case
- An Abdominal Desmoid Tumor Involving the Xyphoid and Costal Chondrium Associated with Pregnancy: Report of a Case
- Impact of Splenectomy and Immunochemotherapy on Survival Following Gastrectomy for Carcinoma: Covariate Interaction with Immunosuppressive Acidic Protein, A Serum Marker for the Host Immune System
- Weekly Schedule of Docetaxel in Breast Cancer: Evaluation of Response and Toxicity
- Aromatase and Aromatase Inhibitors
- Overexpression of MDM2 in MCF-7 Promotes Both Growth Advantage and p53 Accumulation in Response to Estradiol
- JMS Report 米国のM・D・アンダーソンがんセンターによる チームオンコロジーメディアセミナー
- MRIが診断に有効であった外傷性右横隔膜ヘルニアの1例
- 817 食道癌術後5年目に左鎖骨下動脈に穿通した再建胃管潰瘍の救命例
- 食道癌術後5年目に左鎖骨下動脈に穿通した再建胃管潰瘍の1例
- What's going on 乳癌 A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, et al. Cancer Cell. 2004;5:607-16. PMID:15193263--術後補助療法におけるタモキシフェンへの反応性
- 乳がん (第46回日本癌治療学会総会Educational Book) -- (教育セッション がん治療update)
- Changes in the Expression of Lipid-Mediated Signal-Transducing Enzymes in the Rat Liver After Partial Hepatectomy
- Usefulness of MR imaging in the postsurgical monitoring of gallbladder cancer in a patient with bile duct cancer that developed 7 years after resection of mucinous adenocarcinoma of the gallbladder
- Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selected estrogen-regulated genes
- Preparation of long sticky ends for universal ligation-independent cloning : Sequential T4 DNA polymerase treatments(METHODS)
- Role of MDM2 Overexpression in Doxorubicin Resistance of Breast Carcinoma
- MDM2 in Breast Cancer
- 国際共同臨床試験
- Use of Continuous Retrograde Gaseous Oxygen Persufflation for Myocardial Protection During Open Heart Surgery
- Clinical usefulness of high-dose toremifene in patients relapsed on treatment with an aromatase inhibitor
- Refractory lung metastasis from breast cancer treated with multidisciplinary therapy including an immunological approach
- Novel Sensitizing Agents : Potential Contribution of COX-2 Inhibitor for Endocrine Therapy of Breast Cancer
- PS-149-3 術前化学療法による腋窩リンパ節転移への治療効果と予後についての検討(PS-149 ポスターセッション(149)乳腺:化学療法-1,第111回日本外科学会定期学術集会)
- Clinicopathological Analysis of Ten Patients with Metaplastic Squamous Cell Carcinoma of the Breast
- Ki67 index changes, pathological response and clinical benefits in primary breast cancer patients treated with 24 weeks of aromatase inhibition
- ER陽性乳がんに対する個別化治療 (特集 乳がんにおける多様性と個別化) -- (薬物療法における個別化)
- Prognostic significance of tumor/stromal caveolin-1 expression in breast cancer patients
- Sex steroid hormones in pairs of tumor and serum from breast cancer patients and pathobiological role of androstene-3β, 17β-diol